Adaptive Biotechnologies CorporationADPTNASDAQ
LOADING
|||
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-15.69%
↓ 179% below average
Average (7y)
19.97%
Historical baseline
Range
High:80.57%
Low:-15.69%
Volatility
481.9%
High variability
| Period | Value |
|---|---|
| 2024 | -15.69% |
| 2023 | -13.85% |
| 2022 | -0.41% |
| 2021 | 22.63% |
| 2020 | 64.16% |
| 2019 | 80.57% |
| 2018 | 22.38% |
| 2017 | 0.00% |